Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric A Collisson

Showing results (51-60 of 98) with videos related to

Pageof 10
Sort By:
Biorxiv : the Preprint Server for Biology|July 29, 2024
Mapping kinase domain resistance mechanisms for the MET receptor tyrosine kinase via deep mutational scanningGabriella O Estevam, Edmond M Linossi, Jingyou Rao, et al.
The Journal of Experimental Medicine|March 9, 2022
Ferrous iron-activatable drug conjugate achieves potent MAPK blockade in KRAS-driven tumorsHonglin Jiang, Ryan K Muir, Ryan L Gonciarz, et al.
BMC Cancer|April 18, 2015
Circulating tumor cells in hepatocellular carcinoma: a pilot study of detection, enumeration, and next-generation sequencing in cases and controlsRobin K Kelley, Mark Jesus M Magbanua, Timothy M Butler, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 5, 2020
Molecular Insights in Transmission of Cancer From an Organ Donor to Four Transplant RecipientsChloe E Atreya, Eric A Collisson, Meyeon Park, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2014
Mapping the molecular determinants of BRAF oncogene dependence in human lung cancerLuping Lin, Saurabh Asthana, Elton Chan, et al.
Cancer Discovery|May 26, 2012
A central role for RAF→MEK→ERK signaling in the genesis of pancreatic ductal adenocarcinomaEric A Collisson, Christy L Trejo, Jillian M Silva, et al.
Nature Communications|May 16, 2018
Cell of origin and mutation pattern define three clinically distinct classes of sebaceous carcinomaJeffrey P North, Justin Golovato, Charles J Vaske, et al.
Cell Reports. Medicine|April 12, 2023
Development of an artificial intelligence-derived histologic signature associated with adjuvant gemcitabine treatment outcomes in pancreatic cancerVivek Nimgaonkar, Viswesh Krishna, Vrishab Krishna, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2017
Stromal cues regulate the pancreatic cancer epigenome and metabolomeMara H Sherman, Ruth T Yu, Tiffany W Tseng, et al.
Nature Medicine|April 16, 2013
A colorectal cancer classification system that associates cellular phenotype and responses to therapyAnguraj Sadanandam, Costas A Lyssiotis, Krisztian Homicsko, et al.
Pageof 10

Showing results (51-60 of 98) with videos related to

Sort By:
Pageof 10
Biorxiv : the Preprint Server for Biology|July 29, 2024
Mapping kinase domain resistance mechanisms for the MET receptor tyrosine kinase via deep mutational scanningGabriella O Estevam, Edmond M Linossi, Jingyou Rao, et al.
The Journal of Experimental Medicine|March 9, 2022
Ferrous iron-activatable drug conjugate achieves potent MAPK blockade in KRAS-driven tumorsHonglin Jiang, Ryan K Muir, Ryan L Gonciarz, et al.
BMC Cancer|April 18, 2015
Circulating tumor cells in hepatocellular carcinoma: a pilot study of detection, enumeration, and next-generation sequencing in cases and controlsRobin K Kelley, Mark Jesus M Magbanua, Timothy M Butler, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 5, 2020
Molecular Insights in Transmission of Cancer From an Organ Donor to Four Transplant RecipientsChloe E Atreya, Eric A Collisson, Meyeon Park, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2014
Mapping the molecular determinants of BRAF oncogene dependence in human lung cancerLuping Lin, Saurabh Asthana, Elton Chan, et al.
Cancer Discovery|May 26, 2012
A central role for RAF→MEK→ERK signaling in the genesis of pancreatic ductal adenocarcinomaEric A Collisson, Christy L Trejo, Jillian M Silva, et al.
Nature Communications|May 16, 2018
Cell of origin and mutation pattern define three clinically distinct classes of sebaceous carcinomaJeffrey P North, Justin Golovato, Charles J Vaske, et al.
Cell Reports. Medicine|April 12, 2023
Development of an artificial intelligence-derived histologic signature associated with adjuvant gemcitabine treatment outcomes in pancreatic cancerVivek Nimgaonkar, Viswesh Krishna, Vrishab Krishna, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2017
Stromal cues regulate the pancreatic cancer epigenome and metabolomeMara H Sherman, Ruth T Yu, Tiffany W Tseng, et al.
Nature Medicine|April 16, 2013
A colorectal cancer classification system that associates cellular phenotype and responses to therapyAnguraj Sadanandam, Costas A Lyssiotis, Krisztian Homicsko, et al.
Pageof 10